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Adverse Impact of a History of Violence for
Women With Breast, Cervical, Endometrial,
or Ovarian Cancer
Susan C. Modesitt, MD, Alisa C. Gambrell, MD, Hope M. Cottrill, MD, Lon R. Hays,
Robert Walker, LCSW, MSW, Brent J. Shelton, PhD, Carol E. Jordan, MS,
and James E. Ferguson II, MD
OBJECTIVE: The experience of physical and sexual violence (victimization) is common among U.S. women and
is associated with adverse health consequences. The
study objectives were to estimate the prevalence of
victimization in women with cancer and to examine
associations with demographics, cancer screening, and
cancer stage.
METHODS: From 2004 to 2005, 101 women with breast,
cervical, endometrial, or ovarian cancer were interviewed to collect demographics, cancer screening history, health care access/use, and violence history. Chisquare and Fisher exact tests were used test risk-factor
associations. A multinomial logistic regression model was
used for multivariable analysis.
RESULTS: The prevalence of a history of violence was
48.5% (49/101 women), and within that group, 46.9%
(23/49) had a positive childhood violence screen, 75.5%
(37/49) had a positive adult screen, and 55% (27/49)
reported sexual violence at any age. Women with a
positive violence screen differed significantly from
women with a negative screen in that they were younger
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(P ⴝ .031), more often divorced (P ⴝ .012), more likely to
smoke (P ⴝ .010), more often lacked commercial insurance (P ⴝ .036), and had more advanced stage of disease
(P ⴝ .013), but they did not differ with regard to race,
cancer type, education level, alcohol or drug use, or
cancer screening compliance. Multivariable analysis revealed that only stage remained significant; women with
a history of violence had a 2.6-fold increased chance of
diagnosis in later stages (odds ratio 2.61, 95% confidence
interval 1.03– 6.59).
CONCLUSION: A history of violence in breast, ovarian,
endometrial, and ovarian cancer patients was extremely
common and correlated with advanced stage at diagnosis.
(Obstet Gynecol 2006;107:1330–6)

LEVEL OF EVIDENCE: II-2

V

iolence in the form of intimate partner victimization remains an extremely common experience
among women, with a lifetime prevalence rate of
approximately 25% of females in the United States.1–3
Physical and sexual victimization inflicted on women
has multisystemic short- and long-term health effects.4
Most immediately, women may sustain acute injuries
as evidenced by emergency room studies showing
that one third of women seeking emergency medical
care for violence-related injuries have been injured by
a current or former spouse.5 In addition to acute
injury, there are documented chronic health effects of
violence toward women. Headaches, back pain, fainting, seizures or related central nervous system complaints, chronic pain, irritable bowel syndrome, pelvic
inflammatory disease, persistent skin disorders, and
adverse pregnancy outcomes have all been found to
be associated with intimate partner victimization.2,6 –16
Not surprisingly, gynecologic issues make up a
frequent source of medical problems in women victimized by violence. These include sexually transmit-
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ted diseases, vaginal bleeding, pelvic pain, and urinary tract infections.2,8,15,17,18 Gynecologic symptoms
have been found to be most severe among women
whose abuse history includes sexual victimization,
and studies find that sexual assault often results in
sexually transmitted diseases, urinary tract infections,
hemorrhoids, and other genitourinary tract problems.3,19,20 Additionally, young girls who were sexually abused will more commonly acquire genital
human papillomavirus (HPV) infection, potentially
leading to development of both cervical dysplasia and
cervical cancer.21,22 Likewise, intimate partner violence in adults has also been associated with an
increased risk of both invasive cervical cancer and
preinvasive cervical dysplasia.23
Although there is extensive literature on the
health problems experienced by women with victimization histories, there is very limited research on the
association of violence with cancer detection and
treatment or cancer related outcomes. One large
study investigated over 9,500 people for a history of
childhood abuse (including psychological, physical,
or sexual abuse, witnessing violence against the
mother, or living with household members who were
substance abusers, mentally ill, or imprisoned) and
found that there was a significant dose-response curve
between the number of childhood exposures and
subsequent diagnosis of a number of significant adverse health events, including cancer.24 Although
exposure to HPV might explain an increased rate of
cervical dysplasia and, potentially, cervical cancer, it
is unclear what other factors might play a role in the
increased rates of other cancers.
Many of the issues listed above are crucial to our
understanding of the long-term health consequences
of violence against women and its potential link to
cancer, but the first step in trying to elucidate the
relationship is to begin to define it. Specifically, the
objectives of this study were threefold. The first
objective was to estimate the prevalence of past and
current victimization and to compare demographic
characteristics between women with and those without a history of victimization. The second objective
was to examine the association between victimization
history and use of cancer screening programs. The
third objective was to examine the associations of a
history of violence with cancer stage at diagnosis in
this sample of oncology clinic patients.

MATERIALS AND METHODS
This study was approved by the Medical Institutional
Review Board at the University of Kentucky. Women
were recruited as a convenience sample from the
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Gynecologic Oncology and Breast Oncology clinics
of the Markey Cancer Center of the University of
Kentucky from April 2004 to August 2005. Inclusion
criteria included diagnosis of breast, cervical, endometrial, or ovarian cancer (either in surveillance or
active treatment) and age over 18. Each woman
signed an informed consent before participating in the
interview on health history and victimization. Before
entry into the study, there was no knowledge on the
part of the interviewers about violence history or
medical history other than type of cancer. Participants
were paid $25.00 after completion of the study.
Interviews were conducted in a private setting
with just the participant and a female interviewer (one
of the authors—S.C.M., H.M.C., or A.C.G.— or one
research assistant). The interview lasted approximately 30 minutes, and the following self-reported
information was collected: age, ethnicity, marital status, education, income, occupation, transportation,
Pap test history, mammogram history, colon cancer
screening history, reproductive and sexual history,
smoking, alcohol use, recreational drug use, health
care access and use, insurance and medical care
(public health, private, emergency room) before diagnosis of cancer, medical history, family history of
cancer, and history of violence/victimization. For the
purposes of this study, violence was defined to include
an experience of either physical assault or sexual
victimization but not perpetration of violence. The
violence screening questions for physical or sexual
victimization were adapted from the National Violence Against Women Survey.25
Data were analyzed with SPSS 13.0 (SPSS Inc,
Chicago, IL) statistical analysis software. Chi-square
tests (and Fisher exact test where appropriate) were
used to test the association between risk factors, and
independent t tests were used to compare means.
Univariable and multivariable analyses were performed with a multinomial logistic regression model26
and 2 tests. A history of violence was the dependent
variable of interest. For all tests, P ⬍ .05 was deemed
statistically significant.

RESULTS
One hundred one women were enrolled and completed the study, and they were nearly equally divided among the 4 cancer types (1 additional breast
cancer patient was enrolled). A total of 125 women
were approached for participation, for a recruitment
success rate of 81%. The lifetime prevalence of a
history of violence for the entire group was 48.5%
(49/101 women; Tables 1 and 2). Looking more
closely at the 49 women who had a positive violence
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Table 1. Comparison of Demographics in Women With and Those Without a History of Violence
Factor
Mean age (y)
Age distribution
ⱕ 50
⬎ 51
Race
White
Black
Marital status
Never married
Currently married
Divorced
Widowed
Highest level of education
ⱕ High school
⬎ High school
Insurance*
Insured (commercial)
Medicaid/Medicare/none
Smoking status
Never a smoker
Past smoker
Current smoker
Alcohol use
Never used
Past use
Current use
Type of cancer
Breast cancer
Cervical cancer
Endometrial cancer
Ovarian cancer
Tumor stage
Early stage (I–II)
Late stage (III–IV)

Positive Violence (n ⴝ 49)

Negative Violence (n ⴝ 52)

P

50.4

55.8

.031

23
26

17
35

.143

45
4

51
1

.148

3
20
19
7

3
37
7
5

33
16

26
26

27
22

39
13

25
9
15

24
22
6

26
14
9

28
16
8

11
14
11
13

15
11
14
12

21
28

35
17

.012

.077

.036

.010

.915

.732

.013

* Commercial insurance category includes all women with commercial insurance (15 women also had supplemental Medicare). A total of
7 women lacked insurance.

screen, 46.9% (23/49) had a positive childhood violence screen, and 75% (37/49) had a positive adult
screen. For both the child and adult violence screening questions, there were 7 possible affirmative answers, and the mean number of positive responses
was higher for adult violence (mean 2.69, range 0 –7)
than for childhood violence (mean 0.98, range 0 – 4).
Of the women with a positive violence screen, 55%
(27/49) reported sexual violence. Subjects were also
asked to quantify the number of incidents (none, 1,
2–10 or ⬎ 10 events), and more often, these were not
isolated violent events. Violence within the last year
was also assessed (Table 2); only 2 patients had any
episode within the year of study completion (both
reported to be in safe situations at the time of disclosure per the human subjects portion of the interview
protocol).
Women with and those without a positive vio-
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lence screen were compared (Table 1) and found to
differ significantly with regard to mean age, (P ⫽
.031), marital status (P ⫽ .012), smoking (P ⫽ .010),
insurance (P ⫽ .036), and stage of disease (P ⫽ .013),
but they did not differ with regard to race, cancer
type, education level, and alcohol or drug use. Specifically, women with a history of violence were
younger, and more of these women were divorced,
smoked, and lacked commercial insurance when
compared with women without a history of violence.
Furthermore, more women who disclosed a history of childhood or adult violence were diagnosed at
advanced stages of disease, despite equivalent adherence to recommended cancer screening protocols for
breast, cervical, and colon cancer. Of note, overall
compliance for breast, cervical, and colon cancer
screening tests was low at 56%, 55%, and 36%,
respectively for the at-risk population, but this did not
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Table 2. Specifics of Violent Experiences for
Women With a Positive Violence Screen
(n ⴝ 49)
n (%)
Childhood violence
Negative violence screen
Positive violence screen
Mean score (range)*
Adult violence
Negative violence screen
Positive violence screen
Mean score (range)*
Sexual violence
Negative sexual violence screen
Positive sexual violence screen
Mean score (range)†
Frequency of violence as a child‡
None
One event
2–10 events
⬎ 10 events
Frequency of violence as an adult‡
None
One event
2–10 events
⬎ 10 events
Frequency of violence in the past year‡
None
One event
2–10 events
⬎ 10 events

26
(53.1)
23
(46.9)
0.98 (0–5)
12
(24.5)
37
(75.5)
2.69 (0–7)
22
(44.9)
27
(55.1)
1.10 (0–4)
24
7
5
13

(49)
(14.3)
(10.2)
(26.5)

8
11
12
18

(16.3)
(22.4)
(24.5)
(36.7)

47
0
1
1

(95.9)
(0)
(2.0)
(2.0)

* The mean score is the average number of positive responses for a
total of 7 questions asked.
†
The mean score is the average number of positive responses for a
total of 5 questions asked.
‡
Includes both violence or sexual violence, so numbers are higher
than the violence-alone data.

differ significantly from the women without a history
of violence (Table 3). Compliance was defined as
adhering to annual Pap test (after sexual activity),
annual mammograms after age 40, and colonoscopy
after age 50. Use of health care was compared between women with and those without a history of
violence. Although the mean number of physician
visits per year before the diagnosis of cancer was
slightly lower in the women with a positive violence
history, this was not statistically significant (mean 2.05
versus 2.98; P ⫽ .137). Women with a positive
victimization history, however, were more likely to
report either not seeing a physician or having relied
on only an emergency room physician in the year
before their cancer diagnoses (18.4% versus 3.8%; P ⫽
.019).
Multivariable analysis of the factors found to be
significantly associated with violence on univariable
analysis (age, marital status, insurance, tobacco use,
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and tumor stage) showed that only the stage of disease
remained a significant factor. Women with a history
of violence had a 2.6-fold increased chance of being
diagnosed in later stages (odds ratio 2.61, 95% confidence interval 1.03– 6.59), whereas neither age, insurance type, tobacco use, or marital status were still
significant (Table 4).

DISCUSSION
Violence against women is a pervasive problem that
crosses racial and socioeconomic boundaries, and its
impact on women’s health is slowly being elucidated.
In U.S. women the lifetime prevalence of intimate
partner violence is estimated at 25%, and the prevalence of any history of violence is as high as 55%.25
Unfortunately, it is often a silent problem because
women are reluctant to volunteer such information to
physicians, and conversely, physicians often are reluctant to ask women about violence. In fact, numerous studies document inadequate screening among
physicians for current or historic victimization in their
female patients, and in turn, poor screening results in
a lack of detection of victimization.27–31 Our study of
women with breast, cervical, endometrial, or ovarian
cancer revealed that half of these women have been
victims of childhood or adult violence and demonstrated that such a history was associated with more
advanced stage at diagnosis. This preliminary finding
suggests an even greater need for physicians to explore victimization in all phases of health care to
encourage patients to pursue screening or diagnostic
assessment for possible cancers to promote earlier
intervention. Although universal screening for violence is certainly stressed in the primary care wellwoman exams or in prenatal care visits, the prevalence of violence history in this sample of cancer
patients is considerably higher than the rates (15–
40%) previously reported in these other populations11,32–34 and should encourage oncologists to
screen all of our patients for violence.
Previous research suggested that women with a
positive violence history may have increased rates of
cancer, but there has been limited research in the
women’s cancer patient population.23,24 The literature
suggests that cancer may go undetected because of
lower rates of health care use among women with
victimization. For example, 1 in 3 women with health
problems from victimization had problems with access to health care in the past year—a number twice
that of women without similar abuse experiences.35
The women in our study who disclosed victimization
more frequently were diagnosed with advanced cancer, and this finding continued to be significant on
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Table 3. Screening Compliance and Health Care Use in Women With and Those Without a History of
Violence
Factor

Positive Violence (n ⴝ 49)

Negative Violence (n ⴝ 52)

P

2.05

2.98

.137
.019*

Number of yearly physician visits prior to cancer
Type of physician seen
None or ER visit only
Family practice
Internal medicine
Obstetrics-gynecology
More than one (FP, IM, or ob-gyn)
Mental health treatment
Yes
No
Compliance with screening
Mammogram†
Yes
No
Pap test
Yes
No
Colonoscopy‡
Yes
No

9
24
2
5
9

2
26
2
8
14

20
29

18
34

17
19

29
18

23
26

34
18

9
18

14
23

.529

.188

.062

.711

ER, emergency room; FP, family practice; IM, internal medicine; ob-gyn, obstetrics-gynecology.
* Comparing women with None or ER-only to women with an identified physician.
†
For women ⱖ 40 years (n ⫽ 83).
‡
For women ⱖ 50 years (n ⫽ 64).

Table 4. Multivariable Analysis of Factors
Correlating With a Positive Violence
History
AHR for Any
Violent Event (95% CI)

Factors
Age
ⱕ 50
⬎ 50
Tobacco use
Past use
Current use
Never used
Marital status
Widowed
Never married
Currently married
Divorced
Stage
Stage I–II
Stage III–IV
Insurance*
Commercial
None/Medicaid/Medicare

P
.220

Reference
0.526 (0.188–1.469)
.248
Reference
0.323 (0.082–1.278)
0.622 (0.187–2.065)
.071
Reference
0.262 (0.025–2.770)
0.385 (0.91–1.628)
1.555 (0.326–7.410)
.040
Reference
2.606 (1.031–6.587)
.364
Reference
1.567 (0.594–4.132)

AHR, adjusted hazard ratio; CI, confidence interval.
* Commercial insurance category includes all women with commercial insurance (15 women also had supplemental Medicare).
A total of 7 women lacked insurance.

multivariable analysis. Possible explanations for these
results could include decreased access to health care
providers, decreased adherence to recommended
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cancer screening, or potentially, increased stress and
compromised immune function. Our data supported
some potential barriers to health care since more
women with abuse lacked commercial insurance and
were divorced compared with the women without
abuse. Although we did not identify a significant
difference in the number of physician visits, we did
find that women with a history of violence were more
likely to rely on emergency department or urgent
treatment visits, which may not include routine comprehensive physical assessment or promote cancer
screening programs. The analysis of insurance, marital status, and screening behaviors did not explain the
differences that were noted in stage of presentation.
This study had limitations that included reliance
on patient self-reports of victimization and health care
use. Although self-reports have been studied and have
established validity, there are possible concerns about
the accuracy of recall. In addition, this study used
limited screening questions and did not examine the
specific victimization experiences or the severity of
victimization. This was also a convenience sample of
female cancer patients in Kentucky who are being
treated in a university setting and may not be representative of the nation as a whole. However, even
with these limitations, this study advances awareness
of the potential role that victimization may play in
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cancer screening use and follow-up treatment among
women.
Future research should examine the specific
health use pathways followed by women with violent
experiences to better understand the relationship of
victimization, health conditions, and health care outcomes. Additionally, further examination of how detection of serious health problems, such as cancers,
can occur earlier and thus potentially improve outcomes for women with a history of victimization is
warranted. Lastly, the physical effects of violence and
potential links to biologic tumor pathways merit
exploration. This study, along with previous data,
underscores the importance of careful screening for
victimization in the health care setting. Future research should clarify how physicians can better identify patients with victimization and improve detection
and treatment of cancer in affected populations.
REFERENCES
1. Campbell J, Jones AS, Dienemann J, Kub J, Schollenberger J,
O’Campo P, et al. Intimate partner violence and physical
health consequences. Arch Intern Med 2002;162:1157–63.

13. McCauley J, Kern DE, Kolodner K, Dill L, Schroeder AF,
DeChant HK, et al. The “battering syndrome”: prevalence and
clinical characteristics of domestic violence in primary care
internal medicine practices. Ann Intern Med 1995;123:737–46.
14. Plichta S. The effects of woman abuse on health care utilization
and health status: a literature review. Womens Health Issues
1992;2:154–63.
15. Plichta S. Violence and abuse: implications for women’s
health. In: Falik, M, Collins K, editors. Women’s health: the
Commonwealth Fund survey. Baltimore (MD): Johns Hopkins
University Press; 1996. p. 237–72.
16. Plichta S, Weisman C. Spouse or partner abuse, use of health
services, and unmet need for medical care in US women.
J Womens Health 1995;4:45–53.
17. Leserman J, Li Z, Drossman DA, Hu YJ. Selected symptoms
associated with sexual and physical abuse history among
female patients with gastrointestinal disorders: the impact on
subsequent health care visits. Psychol Med 1998;28:417–25.
18. Letourneau EJ, Holmes M, Chasedunn-Roark J. Gynecologic
health consequences to victims of interpersonal violence.
Womens Health Issues 1999;9:115–20.
19. Eby KK, Campbell JC, Sullivan CM, Davidson WS 2nd.
Health effects of experiences of sexual violence for women
with abusive partners. Health Care Women Int 1995;16:
563–76.

2. Campbell JC. Health consequences of intimate partner violence. Lancet 2002;359:1331–6.

20. El-Bassel N, Gilbert L, Krishnan S, Schilling R, Gaeta T,
Purpura S, et al. Partner violence and sexual HIV-risk behaviors among women in an inner-city emergency department.
Violence Vict 1998;13:377–93.

3. Campbell JC, Soeken KL. Forced sex and intimate partner
violence: effects on women’s risk and women’s health. Violence Against Women 1999;5:1017–35.

21. Farley M, Golding JM, Minkoff JR. Is a history of trauma
associated with a reduced likelihood of cervical cancer screening? J Fam Pract 2002;51:827–31.

4. Logan TK, Walker R, Jordan CJ, Leukefeld C. Women and
victimization: contributing factors, interventions, and implications. Washington, DC: American Psychological Press; 2005.

22. Stevens-Simon C, Nelligan D, Breese P, Jenny C, Douglas JM
Jr. The prevalence of genital human papillomavirus infections
in abused and nonabused preadolescent girls. Pediatrics 2000;
106:645–9.

5. Rand MR, Strom K. Violence-related injuries treated in hospital emergency departments. Bur Justice Stat Spec Rep 1997:
1–11.
6. Leserman J, Li Z, Drossman DA, Toomey TC, Nachman G,
Glogau L. Impact of sexual and physical abuse dimensions on
health status: development of an abuse severity measure.
Psychosom Med 1997;59:152–60.
7. Diaz-Olavarrieta C, Campbell J, Garcia de la Cadena C, Paz F,
Villa AR. Domestic violence against patients with chronic
neurologic disorders. Arch Neurol 1999;56:681–5.
8. Coker AL, Smith PH, Bethea L, King MR, McKeown RE.
Physical health consequences of physical and psychological
intimate partner violence. Arch Fam Med 2000;9:451–7.
9. Plichta SB, Duncan MM, Plichta L. Spouse abuse, patientphysician communication, and patient satisfaction. Am J Prev
Med 1996;12:297–303.

23. Coker AL, Sanderson M, Fadden MK, Pirisi L. Intimate
partner violence and cervical neoplasia. J Womens Health
Gend Based Med 2000;9:1015–23.
24. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM,
Edwards V, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in
adults. The Adverse Childhood Experiences (ACE) Study. Am
J Prev Med 1998;14:245–58.
25. Tjadden P, Thoennes N. Prevalence, incidence, and consequences of violence against women: findings from the
National Violence Against Women Survey. Washington,
DC: National Institute of Justice Centers for Disease Control
and Prevention; 1998.
26. Stokes M, Davis C, Koch GG. Categorical data analysis using
the SAS system. Cary (NC): SAS Institute; 2000.

10. Yost NP, Bloom SL, McIntire DD, Leveno KJ. A Prospective
Observational Study of Domestic Violence During Pregnancy.
Obstet Gynecol 2005;106:61–5.

27. Gerbert B, Bronstone A, Pantilat S, McPhee S, Allerton M,
Moe J. When asked, patients tell: disclosure of sensitive
health-risk behaviors. Med Care 1999;37:104–11.

11. Coker AL, Sanderson M, Dong B. Partner violence during
pregnancy and risk of adverse pregnancy outcomes. Paediatr
Perinat Epidemiol 2004;18:260–9.

28. Horan DL, Chapin J, Klein L, Schmidt LA, Schulkin J.
Domestic violence screening practices of obstetrician-gynecologists. Obstet Gynecol 1998;92:785–9.

12. Dutton M, Haywood Y, El-Bayoumi G. Impact of violence on
women’s health. In: Gallant, S, Buryear Keita, G, RoyakSchalar R, editors. Health care for women: psychological,
social and behavioral influences. Washington, DC: American
Psychological Association; 1997. p. 41–56.

VOL. 107, NO. 6, JUNE 2006

29. Krimm J, Heinzer MM. Domestic violence screening in the
emergency department of an urban hospital. J Natl Med Assoc
2002;94:484–91.
30. Wenzel JD, Monson CL, Johnson SM. Domestic violence:

Modesitt et al

Impact of Violence on Cancer

1335

prevalence and detection in a family medicine residency clinic.
J Am Osteopath Assoc 2004;104:233–9.
31. Zink T, Jacobson CJ Jr, Regan S, Pabst S. Hidden victims: the
healthcare needs and experiences of older women in abusive
relationships. J Womens Health (Larchmt) 2004;13:898–908.
32. Naumann P, Langford D, Torres S, Campbell J, Glass N.
Women battering in primary care practice. Fam Pract 1999;
16:343–52.
33. Cokkinides VE, Coker AL, Sanderson M, Addy C, Bethea

L. Physical violence during pregnancy: maternal complications
and birth outcomes. Obstet Gynecol 1999;93:661–6.
34. Diaz-Olavarrieta C, Ellertson C, Paz F, de Leon SP, AlarconSegovia D. Prevalence of battering among 1780 outpatients at
an internal medicine institution in Mexico. Soc Sci Med
2002;55:1589–602.
35. Scott Collins K, Schoen C, Joseph S, Duchon L, Simantov E,
Yellowitz M. Health concerns across a woman’s lifespan: the
Commonwealth Fund 1998 survey of women’s health. New
York (NY): The Commonwealth Fund; 1999.

Search the World's Premier Medical Research!
Special Member-Only Access to OVID Online
ACOG members can access many of the world's premier medical journals online through
Ovid. In these highly cited journals, you're sure to find the content resources you need to
answer your clinical and research questions and advance your medical knowledge.
Ovid offers you:
· Full-text online access to selected Lippincott Williams & Wilkins publications
· Ability to search across the Ovid platform
· Access to Ovid Medline
To access Ovid online:
· Enter the member section at www.acog.org
· Under the “Information” tab, click on the link to “Search Ovid”

1336

Modesitt et al

Impact of Violence on Cancer

OBSTETRICS & GYNECOLOGY

